Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2006-10-17
2006-10-17
Chan, Christina (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S130100, C424S133100
Reexamination Certificate
active
07122186
ABSTRACT:
The present invention relates to a new member of the serine protease family, Ztryp3. Members of this family play a role in carefully controlled processes, such as blood coagulation, fibrinolysis, complement activation, fertilization, and hormone production. These enzymes are also used in a variety of diagnostic, therapeutic, and industrial contexts.
REFERENCES:
patent: 6468776 (2002-10-01), Conklin
patent: 7049126 (2006-05-01), Conklin
Hiller, L., et al., “WashU-Merk EST Project 1997,” Accession No. AA424197 (created: May 22, 1997).
Hiller, L., et al., “WashU-Merk EST Prjoect 1997,” Accession No. AA461584 (created: Jun. 13, 1997).
Strausberg, R., “National Cancer Institute, Cancer Genome Anatomy Project (CGAT), Tumor Gene Index,” Accession No. A1805861 (created: Jul. 8, 1999).
Kawal et al., SPTRGMBL accession No. Q9DAA4, Jun. 1, 2001.
Carninci et al., UniProt accession No. Q9DAA4, Jun. 1, 2001.
Chan Christina
Kim Yunsoo
Walker Shelby J.
ZymoGenetics Inc.
LandOfFree
Human serine protease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human serine protease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human serine protease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714521